BSX Boston Scientific Corp

Five-factor quant read, peer ranking, and the analyst team's own call.

8.4
composite/ 10
Value computed
9.4

priced for 6.6% growth vs 16.5% delivered · +452% to base-case fair value

Quality computed
7.5

Piotroski 6/8 · Altman safe zone · ROE 12% · interest covered 11x

Momentum
-
Defensive
-
Tactical
-

Descriptive, not predictive. Momentum, Defensive and Tactical are deciles within our liquid universe; Value and Quality are computed from filed financials. None of them forecasts a return - the model's out-of-sample AUC is published in the whitepaper.

Peer comparison

Composite score against sector peers · 6 names

#1
8.4
#2
6.9
#3
6.7
#4
6.7
#5
6.7
#6
4.6

BSX ranks #1 of 6 · peer average 6.7

No current desk call on BSX. The factor scores above are computed; a full analysis is four analyst desks, a bull-vs-bear debate and a risk committee, and takes about three minutes.

Automated, educational research - not investment advice, and not a recommendation to buy or sell any security.